Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2/6/25 16:52 | 2/4/25 | DNA | Health | BioPrd | Biological Products, (No Diag | Coen Steven P. | MA | O | See rema | 10 | S.d | -147 | 0.8255 | 0 | -178 | 207 | D | |||||||||||||||
2/6/25 16:50 | 2/4/25 | DNA | Health | BioPrd | Biological Products, (No Diag | Dmytruk Mark E. | MA | O | See Rema | 17 | S.d | -563 | 1.10 | 0 | -512 | 1,088 | D | |||||||||||||||
5/20/24 16:54 | 5/16/24 | DNA | Health | BioPrd | Biological Products, (No Diag | Dekkers Marijn E | MA | D | 2 | S | -1,826 | 0.9167 | 0 | -1,992 | 6,062 | I | ||||||||||||||||
1/5/24 17:11 | 1/3/24 | DNA | Health | BioPrd | Biological Products, (No Diag | Kelly Jason R | MA | DO | See rema | 13 | S.m | -3,943 | 1.52 | 0 | -2,600 | 6,295 | D | |||||||||||||||
12/22/23 16:59 | 12/20/23 | DNA | Health | BioPrd | Biological Products, (No Diag | Canton Barry | MA | T | 12 | S.m | -1,368 | 1.51 | 0 | -904 | 25,577 | M | ||||||||||||||||
12/22/23 16:55 | 12/20/23 | DNA | Health | BioPrd | Biological Products, (No Diag | Shetty Reshma P. | MA | DOT | See rema | 12 | S.m | -1,368 | 1.51 | 0 | -904 | 25,577 | M | |||||||||||||||
11/6/23 17:23 | 11/2/23 | DNA | Health | BioPrd | Biological Products, (No Diag | Henry Christian O | MA | D | 3 | S.e | -19 | 1.39 | 0 | -13 | 1,239 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |